{"entity":{"type":"insider","cik":"0001873085","url":"/insider/0001873085","json_url":"/insider/0001873085.json","name":"Jeanmonod Patrik","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":18,"first":"2022-08-03","last":"2023-12-27","span_basis":"filed_date"},"name_variants":[{"name":"Jeanmonod Patrik","source":"filing","n_filings":18,"first_seen":"2022-08-03","last_seen":"2023-12-27"}],"transactions":[{"id":8336081,"accession":"0001209191-23-059819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-059819","line_url":"/filing/0001209191-23-059819#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":28500.0,"total_display":"28,500.00","shares_owned_after":93400.0,"shares_owned_after_display":"93,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-26","filed_date":"2023-12-27","scope":"insider"},{"id":7872171,"accession":"0001209191-23-056733","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-056733","line_url":"/filing/0001209191-23-056733#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.94,"price_display":"6.94","price_state":"stated","total_value":20820.0,"total_display":"20,820.00","shares_owned_after":96400.0,"shares_owned_after_display":"96,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-24","filed_date":"2023-11-27","scope":"insider"},{"id":8255197,"accession":"0001209191-23-053595","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053595","line_url":"/filing/0001209191-23-053595#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":14040.0,"total_display":"14,040.00","shares_owned_after":96084.0,"shares_owned_after_display":"96,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-24","filed_date":"2023-10-25","scope":"insider"},{"id":7899538,"accession":"0001209191-23-050611","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050611","line_url":"/filing/0001209191-23-050611#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.38,"price_display":"6.38","price_state":"stated","total_value":19140.0,"total_display":"19,140.00","shares_owned_after":99084.0,"shares_owned_after_display":"99,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-25","filed_date":"2023-09-26","scope":"insider"},{"id":8078623,"accession":"0001209191-23-047533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-047533","line_url":"/filing/0001209191-23-047533#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.69,"price_display":"7.69","price_state":"stated","total_value":23070.0,"total_display":"23,070.00","shares_owned_after":102084.0,"shares_owned_after_display":"102,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-28","scope":"insider"},{"id":7922964,"accession":"0001209191-23-043340","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-043340","line_url":"/filing/0001209191-23-043340#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":9.17,"price_display":"9.17","price_state":"stated","total_value":27510.0,"total_display":"27,510.00","shares_owned_after":101768.0,"shares_owned_after_display":"101,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-24","filed_date":"2023-07-25","scope":"insider"},{"id":7898479,"accession":"0001209191-23-039967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-039967","line_url":"/filing/0001209191-23-039967#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.96,"price_display":"7.96","price_state":"stated","total_value":23880.0,"total_display":"23,880.00","shares_owned_after":104768.0,"shares_owned_after_display":"104,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-26","filed_date":"2023-06-27","scope":"insider"},{"id":7870044,"accession":"0001209191-23-032259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-032259","line_url":"/filing/0001209191-23-032259#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.76,"price_display":"7.76","price_state":"stated","total_value":23280.0,"total_display":"23,280.00","shares_owned_after":107768.0,"shares_owned_after_display":"107,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-24","filed_date":"2023-05-25","scope":"insider"},{"id":8019718,"accession":"0001209191-23-025617","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-025617","line_url":"/filing/0001209191-23-025617#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":10.24,"price_display":"10.24","price_state":"stated","total_value":30720.0,"total_display":"30,720.00","shares_owned_after":108201.0,"shares_owned_after_display":"108,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-24","filed_date":"2023-04-25","scope":"insider"},{"id":8606777,"accession":"0001209191-23-021140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-021140","line_url":"/filing/0001209191-23-021140#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":8.33,"price_display":"8.33","price_state":"stated","total_value":24990.0,"total_display":"24,990.00","shares_owned_after":111201.0,"shares_owned_after_display":"111,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-24","filed_date":"2023-03-24","scope":"insider"},{"id":7896739,"accession":"0001209191-23-013889","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-013889","line_url":"/filing/0001209191-23-013889#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":11.05,"price_display":"11.05","price_state":"stated","total_value":33150.0,"total_display":"33,150.00","shares_owned_after":114201.0,"shares_owned_after_display":"114,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-28","scope":"insider"},{"id":8677341,"accession":"0001209191-23-004922","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004922","line_url":"/filing/0001209191-23-004922#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":11.05,"price_display":"11.05","price_state":"stated","total_value":38675.0,"total_display":"38,675.00","shares_owned_after":76132.0,"shares_owned_after_display":"76,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-24","filed_date":"2023-01-25","scope":"insider"},{"id":6498168,"accession":"0001209191-22-062882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062882","line_url":"/filing/0001209191-22-062882#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":9.77,"price_display":"9.77","price_state":"stated","total_value":34195.0,"total_display":"34,195.00","shares_owned_after":79632.0,"shares_owned_after_display":"79,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-29","scope":"insider"},{"id":6658742,"accession":"0001209191-22-058890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-058890","line_url":"/filing/0001209191-22-058890#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":50050.0,"total_display":"50,050.00","shares_owned_after":83132.0,"shares_owned_after_display":"83,132","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-25","filed_date":"2022-11-28","scope":"insider"},{"id":6658298,"accession":"0001209191-22-054563","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-054563","line_url":"/filing/0001209191-22-054563#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":15.16,"price_display":"15.16","price_state":"stated","total_value":53060.0,"total_display":"53,060.00","shares_owned_after":85563.0,"shares_owned_after_display":"85,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-24","filed_date":"2022-10-25","scope":"insider"},{"id":6787397,"accession":"0001209191-22-051488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-051488","line_url":"/filing/0001209191-22-051488#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":12.63,"price_display":"12.63","price_state":"stated","total_value":44205.0,"total_display":"44,205.00","shares_owned_after":89063.0,"shares_owned_after_display":"89,063","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-26","filed_date":"2022-09-28","scope":"insider"},{"id":6926090,"accession":"0001209191-22-047576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047576","line_url":"/filing/0001209191-22-047576#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":13.45,"price_display":"13.45","price_state":"stated","total_value":47075.0,"total_display":"47,075.00","shares_owned_after":92563.0,"shares_owned_after_display":"92,563","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-25","scope":"insider"},{"id":6497214,"accession":"0001209191-22-044309","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-044309","line_url":"/filing/0001209191-22-044309#line-1","is_derivative":false,"issuer_cik":"0001831915","issuer_name":"Cytek Biosciences, Inc.","issuer_ticker":"CTKB","issuer_name_source":null,"issuer_url":"/issuer/0001831915","owner_cik":"0001873085","owner_name":"Jeanmonod Patrik","owner_url":"/insider/0001873085","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3500.0,"shares_display":"3,500","price_per_share":12.8,"price_display":"12.80","price_state":"stated","total_value":44800.0,"total_display":"44,800.00","shares_owned_after":94994.0,"shares_owned_after_display":"94,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-01","filed_date":"2022-08-03","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831915","name":"Cytek Biosciences, Inc.","url":"/issuer/0001831915","role":"Officer (Chief Financial Officer)","n_filings":18,"first_seen":"2022-08-03","last_seen":"2023-12-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001873085","retrieved_at":"2026-08-20T22:59:27+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}